GlassScriptPhysician profile
Cody A Jorgensen
NPI 1104280080
$2,154.67
in general payments reported to CMS, 2019-2025
36 companies · $655 in 2025
The $655 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $93.66 · 2021: $61.65 · 2022: $500 · 2023: $480 · 2024: $263 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,397.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $269.87 | 2021-2025 | Qelbree |
| Corium, LLC | $201.20 | 2022-2024 | Azstarys |
| Pfizer INC. | $170.79 | 2022-2025 | |
| Glaxosmithkline, LLC. | $151.77 | 2022-2023 | Bexsero, Rotarix, Pediarix |
| Merck Sharp & Dohme LLC | $143.50 | 2020-2024 | Vaxneuvance, Gardasil 9, Rotateq |
| Novo Nordisk INC | $115.49 | 2023-2025 | Wegovy, Ozempic |
| Seqirus USA INC | $88.31 | 2024-2025 | Flucelvax, Fluad |
| Cranial Technologies, INC | $82.11 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $80.97 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $71.51 | 2025 | Zoryve |
| Boston Scientific Corporation | $58.54 | 2024 | Wavewriter Alpha Prime 16, Watchman Flx |
| Idorsia Pharmaceuticals US INC | $48.52 | 2023 | Quviviq |
| Abbvie INC. | $46.02 | 2022 | |
| Tris Pharma INC | $45.91 | 2019-2020 | |
| Neos Therapeutics, LP | $44.36 | 2019-2021 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Jorgensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.